1983: Q&A with Oncimmune CEO, Martin Gouldstone

The Vox Markets Podcast · Nov 11, 2024 · 19m

Watch on YoutubeIn this fascinating interview, CEO Martin Gouldstone of Oncimmune #ONC takes Vox through:00:00. What the company does, its key USPs and how the proprietary IMMUNOinsights autoantibody profiling service helps Biopharma companies develop & monitor new drugs & precision medicines.08:30 Current demand picture, breakeven revenue & Aug FY25 visibility.